Cancer Therapeutics, Inc.TM Company Profile

17:23 EDT 18th March 2018 | BioPortfolio

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized disease. Treatments such as surgery, chemotherapy and radiation work well for some patients, but may not be effective for others. Therefore, Biotherapy has become the fourth method for treating cancer.


210 W. Hansell St.
United States of America


Phone: 229.224.6839
Fax: 229.551.0446

News Articles [4084 Associated News Articles listed on BioPortfolio]

GeneCentric Therapeutics Announces Research Collaboration on Drug Response to Biomarkers for Lung Cancer

DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics, Inc. today announced a research collaboration to evaluate the potential of GeneCentric’s Cancer Subtype Platform (CSP®) to identif...

G1 Therapeutics to initiate Phase Ib/II trial for lung cancer

G1 Therapeutics has entered a clinical trial collaboration to assess its G1T38 in combination with AstraZeneca’s Tagrisso (osimertinib) in a...Read More... The post G1 Therapeutics to initiate Phase...

AstraZeneca and G1 Therapeutics in Lung Cancer Pact

AstraZeneca and GI Therapeutics, a US clinical-stage oncology company, are collaborating to test a new combination therapy for lung cancer. The parties will evaluate AstraZeneca’s Tagrisso with ...

Celgene & Juno Therapeutics announce landmark deal for CAR-T Cancer Therapies

Celgene and Juno Therapeutics have announced a decade long collaboration to advance potentially groundbreaking immunotherapies for patients with cancer and autoimmune diseases. The two companies will ...

ADC Therapeutics raises $200m to advance antibody-based cancer treatments

Switzerland-based oncology drug discovery and development company ADC Therapeutics (ADCT) has closed $200m private financing to fund registrational trials of its two lead cancer programs.

Prescient Therapeutics (PTX) - PTX-100 to target RhoA-mutant lymphomas

Edison Investment Research - Pharmaceutical & healthcare - Prescient Therapeutics: Prescient Therapeutics is planning a clinical trial of PTX-100 in RhoA-mutant lymphomas, a niche indication where the...

Crown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the American Association for Cancer Research’s International Conference on Molecular Targets and Cancer Therapeutics

SANTA CLARA, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development...

Galera Therapeutics Doses First Patient in Pancreatic Cancer Trial

Galera Therapeutics has initiated its Phase I/II clinical trial of GC4419 in locally advanced pancreatic cancer (LAPC).

PubMed Articles [6465 Associated PubMed Articles listed on BioPortfolio]

State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report.

In May 2016, the Office of Cancer Complementary and Alternative Medicine, Division of Cancer Diagnosis and Treatment, of the National Cancer Institute convened a special workshop focused on the State ...

Cancer Control Algorithm.

Curing cancer by controlling the growth of the cancer cell is the objective of this paper. The growth of the cancer cell is analysed by the optimization programming. The algorithm is proposed for mini...

New Designs for Basket Clinical Trials in Oncology.

The established molecular heterogeneity of human cancers has had profound effects on the design of cancer therapeutics. Most cancer drugs are today targeted to molecular alterations present in cancer ...

Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.

Breast cancer pathobiology is known to be influenced by the differential expression of a group of proteins called the kinesin superfamily (KIFs), which is instrumental in the intracellular transport o...

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Clinical Trials [7379 Associated Clinical Trials listed on BioPortfolio]

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumorsfor

T-1101 is a novel anti-cancer agent being developed by Taivex Therapeutics Corporation, and is being studied in a phase I dose escalation trial, protocol TAI-001. That trial's primary aim ...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [2489 Associated Companies listed on BioPortfolio]

Advanced Cancer Therapeutics (ACT)

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative ...

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped unde...

BioCancell Therapeutics

BioCancell Therapeutics Inc. is a biopharmaceuticals corporation specializing in the development of Targeted Cancer Therapy for the treatment of numerous types of cancer. The Comp...

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Th...

Elstar Therapeutics, Inc.

Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics.

More Information about "Cancer Therapeutics, Inc.TM" on BioPortfolio

We have published hundreds of Cancer Therapeutics, Inc.TM news stories on BioPortfolio along with dozens of Cancer Therapeutics, Inc.TM Clinical Trials and PubMed Articles about Cancer Therapeutics, Inc.TM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cancer Therapeutics, Inc.TM Companies in our database. You can also find out about relevant Cancer Therapeutics, Inc.TM Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record